Loading...

225 posters, 34 videos, 18 topics, 14 sessions, 251 authors, 55 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

ISMICS 2024 Annual Meeting

29 May - 1 June, 2024 | Athens, Greece

ISMICS 2024 Annual Meeting banner

PC.10

Sutureless Valve Outcomes In Isolated Aortic Valve Replacement By Surgical Approach From A Prospective International Registry

Poster Presenter

Marco Solinas

Part of Topic

Aortic Valve Surgery

SUTURELESS VALVE OUTCOMES IN ISOLATED AORTIC VALVE REPLACEMENT BY SURGICAL APPROACH FROM A PROSPECTIVE INTERNATIONAL REGISTRY

Marco Solinas,1 Max Baghai 2, Giuseppe Santarpino 3, Alistair Royse 4, Maximilian Scherner 5, Giovanni Troise 6, Giovanni Concistrè1, Mattia Glauber7

1 Fondazione Toscana Gabriele Monasterio, Massa, Italy; 2King's College Hospital NHS Foundation Trust, London, United Kingdom; 3Città di Lecce Hospital, GVM Care & Research, Lecce, Italy; 4The Royal Melbourne Hospital, Parkville, Australia; 5University of Magdeburg, Magdeburg, Germany; 6 Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy; 7Gruppo San Donato, Milano, Italy

OBJECTIVE

Sutureless valves have been in clinical use for more than 15 years.

Aim of this study is to report clinical and haemodynamic performance from a real-word registry in patients who underwent aortic valve replacement (AVR) with the Perceval sutureless bioprosthesis, comparing outcomes by surgical approaches.

METHODS

•Prospective international registry
•1652 patients implanted with a sutureless aortic valve in 55 institutions from 2011 to 2021.
•Postoperative, follow-up, and echocardiographic outcomes
•Isolated AVR (1051 pts) analyzed by minimally invasive (MICS) and full sternotomy (full) approaches.
•Preoperative covariates were adjusted with propensity score matching 2:1
•Final cohort of 857 isolated AVR:
•558 patients in MICS
299 in full groups

RESULTS

CONCLUSIONS

This registry represents the largest prospective real-world cohort of patients treated with the Perceval sutureless valve. Our propensity matched analysis demonstrates the non-inferiority of minimally invasive surgery with regards to hard endpoints, like mortality and stroke, and better outcomes for secondary endpoints as reduced length of intensive care and in-hospital stay.

ismics2024 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.